Keywords: Cancer, Radiomics
Motivation: Medulloblastoma (MB) is classified into different molecular (WNT, SHH, Group 3, and Group 4) subgroups. Accurate identification of molecular subgroups provides clinical value to the diagnosis of MB.
Goal(s): We aim to combine APT MRI and radiomic analysis to establish signatures for distinguishing molecular subgroups of pediatric medulloblastoma.
Approach: Fifty newly diagnosed pediatric patients with medulloblastoma were enrolled in this study. Radiomic features were extracted from APT-related metrics to differentiate MB subgroups.
Results: APT MRI-based radiomic signatures exhibited favorable performance in identifying WNT, SHH, Group 3, and Group 4 subgroups with AUCs ≥ 0.91.
Impact: Our research findings demonstrate that amide proton transfer MRI-based radiomic analysis offers a noninvasive and cost-effective method to distinguish molecular subgroups and holds great potential in providing valuable clinical insights for the diagnosis of pediatric medulloblastoma patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords